Cardiovascular disease risk profile in psoriasis patients with and without treatment response in the pristine study

被引：0
|
作者：
Kirby, B. [1 ]
Mrowietz, U. [2 ]
Szumski, A. [3 ]
Jones, H. [3 ]
Malbris, L. [4 ]
机构：
[1] St Vincents Univ Hosp, Deptartment Dermatol, Dublin 4, Ireland
[2] Univ Med Ctr Schleswig Holstein, Psoriasis Ctr, Deptartment Dermatol, Kiel, Germany
[3] Pfizer Inc, Specialty Care, Collegeville, PA USA
[4] Pfizer Inc, Med Affairs Europe, Pfizer Specialty Care, Inflammat, Rome, Italy
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2013年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P073
引用
收藏
页码：31 / 32
页数：2
相关论文
共 50 条
  • [31] The Heartbreak of Psoriasis A Review of Cardiovascular Risk in Patients With Psoriasis
    Benson, Max M.
    Frishman, William H.
    CARDIOLOGY IN REVIEW, 2015, 23 (06) : 312 - 316
  • [32] Myocardial perfusion is preserved in patients with psoriasis without clinically evident cardiovascular disease
    Yalcin, H.
    Balci, D. D.
    Ucar, E.
    Ozcelik, N.
    Tasci, C.
    Seyfeli, E.
    Akgul, F.
    Yalcin, F.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (07) : 798 - 802
  • [33] Antihypertensive Treatment of Patients With Cardiovascular Disease but Without Hypertension
    LaRiccia, Patrick J.
    Morgan, Sherry
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (21): : 2170 - 2171
  • [34] Lifestyle study and psychosocial profile of patients at cardiovascular risk
    Hurtaud, Aline
    Lebeau, Jean-Pierre
    EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2012, 23 (100): : 16S - 17S
  • [35] Does the risk profile of patients with cardiovascular disease and/or diabetes modify initial response to treatment with sibutramine? A preliminary analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial
    Caterson, I
    Sharma, A. M.
    Coutinho, W.
    Finer, N.
    Van Gaal, L.
    Maggioni, A.
    Torp-Pedersen, C.
    James, W. P. T.
    INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 : S100 - S100
  • [36] Approach to the Treatment of Atrial Fibrillation in Patients with Cardiovascular Risk Profile: Multicentric International Study
    Pavlovic, Sinisa U.
    Kircanski, Bratislav
    Radovanovic, Nikola
    Raspopovic, Srdjan
    Jovanovic, Velibor
    Nikcevic, Gabrijela
    Zivkovic, Mirjana
    Milasinovic, Goran
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2015, 143 (9-10) : 551 - 558
  • [37] Psoriasis and risk of nonfatal cardiovascular disease in US women: a cohort study
    Li, W. -Q.
    Han, J. -L.
    Manson, J. E.
    Rimm, E. B.
    Rexrode, K. M.
    Curhan, G. C.
    Qureshi, A. A.
    BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (04) : 811 - 818
  • [38] Cardiovascular risk profile in Greek patients with inflammatory bowel disease
    Tsoukali, E.
    Mantaka, A.
    Orfanoudaki, E.
    Viazis, N.
    Pitsavos, C.
    Panagiotakos, D.
    Mantzaris, G.
    Koutroubakis, I.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S520 - S520
  • [39] Risk and predictors of cardiovascular disease in psoriasis: a population-based study
    Maradit-Kremers, Hilal
    Dierkhising, Ross A.
    Crowson, Cynthia S.
    Icen, Murat
    Ernste, Floranne C.
    McEvoy, Marian T.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2013, 52 (01) : 32 - 40
  • [40] Management of cardiovascular disease in patients with psoriasis
    Egeberg, Alexander
    Skov, Lone
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (11) : 1509 - 1516
12345